Epsis and SIRS groups (Table S3). Interestingly, patients with septic shock Licochalcone-A exhibited lower concentrations of two major NK-cell stimulating cytokines, IL-12 (p = 0.035) and IL-18 (p = 0.054) than those with severe sepsis (Table S3).Phenotype of NK Cells in ICU PatientsCirculating NK cells were phenotyped to define subsets of NK cells according to surface markers and to evaluate expression of activating and inhibitory receptors susceptible to being influenced by NK-cell function. The relative proportions CD3 D56dim and CD3 D56bright NK-cell subsets were similar in patients with Sepsis, SIRS (Table 2) and comparable to the normal values of our laboratory. CD56dim NK cells were the main source of IFN-c secretion (data not shown). Except for higher proportion of KIR3DL1+ NK cells, no difference in expression of either activating (i.e., CD16, NKp30, NKp46, and NKG2D) or inhibitory membrane receptors (i.e., KIR, NKG2A) was observed between Sepsis group and SIRS group patients (Table 2), as well as between patients with severe sepsis or septic shock (data not shown).NK Status on Admission and OutcomesConsidering ICU morbidity, NK-cell functions at admission to the ICU were not correlated to the further occurrence of nosocomial infections (including bacterial VAP and CMV reactivation) or to the length of mechanical ventilation or ICU stay. NK-cell functions at admission to the ICU were also not correlated with severity scores (data not shown). Considering mortality in all ICU patients, T-cell lymphopenia was more severe among non-survivors (654/mm3 [504?030] in survivors vs. 392/ mm3 [313?07] in non-survivors, p = 0.047). But no 520-26-3 quantitative (NK-cell count and percentage) or qualitative (NK-cell phenotype and functions) differences were observed between survivors and non-survivors, either in overall ICU patients or in the subset of septic patients (data not shown).NK Cells and Critically-Ill Septic PatientsNK Cells and Critically-Ill Septic PatientsFigure 2. Evaluation of NK cell functions in ICU septic patients. NK degranulation (A) and intracellular production of IFN-c (B) of ICU patients with Sepsis, SIRS, and healthy controls. A: Degranulation responses by CD107a cell-surface expression ( of positive NK cells) against K562 target cells (natural cytotoxicity) or P815 mouse mastocytoma cells coated with rabbit anti-mouse lymphocyte antibodies (ADCC). B: Intracellular IFN-c expression (percentage of positive NK cells), against K562 target cells or P815 (ADCC). Number of samples from each group: Sepsis group (n = 29), SIRS group (n = 13), and healthy controls (n = 21). A black bar inside the box-and-whiskers plots indicates the median. p(kw): Comparison between healthy, SIRS and Sepsis groups by Kruskal-Wallis test. p: pairwise comparisons between groups (healthy, SIRS, Sepsis) by Kruskal-Wallis post oc methods for multiple comparisons adjusted by step-up Simes method. doi:10.1371/journal.pone.0050446.gDiscussionMortality from severe sepsis and septic shock is still dramatically high, in spite of major advances in critical-care medicine [3]. Massive activation of mononuclear phagocytes by bacterial components and release of proinflammatory cytokines [2] are rapidly compensated for by an anti-inflammatory response, also called immunoparalysis or CARS, which can cause secondary nosocomial infections and death [4,5]. Patients may exhibit both hyper-inflammation and immune paralysis concomitantly, with one being transiently dominant over the other.Epsis and SIRS groups (Table S3). Interestingly, patients with septic shock exhibited lower concentrations of two major NK-cell stimulating cytokines, IL-12 (p = 0.035) and IL-18 (p = 0.054) than those with severe sepsis (Table S3).Phenotype of NK Cells in ICU PatientsCirculating NK cells were phenotyped to define subsets of NK cells according to surface markers and to evaluate expression of activating and inhibitory receptors susceptible to being influenced by NK-cell function. The relative proportions CD3 D56dim and CD3 D56bright NK-cell subsets were similar in patients with Sepsis, SIRS (Table 2) and comparable to the normal values of our laboratory. CD56dim NK cells were the main source of IFN-c secretion (data not shown). Except for higher proportion of KIR3DL1+ NK cells, no difference in expression of either activating (i.e., CD16, NKp30, NKp46, and NKG2D) or inhibitory membrane receptors (i.e., KIR, NKG2A) was observed between Sepsis group and SIRS group patients (Table 2), as well as between patients with severe sepsis or septic shock (data not shown).NK Status on Admission and OutcomesConsidering ICU morbidity, NK-cell functions at admission to the ICU were not correlated to the further occurrence of nosocomial infections (including bacterial VAP and CMV reactivation) or to the length of mechanical ventilation or ICU stay. NK-cell functions at admission to the ICU were also not correlated with severity scores (data not shown). Considering mortality in all ICU patients, T-cell lymphopenia was more severe among non-survivors (654/mm3 [504?030] in survivors vs. 392/ mm3 [313?07] in non-survivors, p = 0.047). But no quantitative (NK-cell count and percentage) or qualitative (NK-cell phenotype and functions) differences were observed between survivors and non-survivors, either in overall ICU patients or in the subset of septic patients (data not shown).NK Cells and Critically-Ill Septic PatientsNK Cells and Critically-Ill Septic PatientsFigure 2. Evaluation of NK cell functions in ICU septic patients. NK degranulation (A) and intracellular production of IFN-c (B) of ICU patients with Sepsis, SIRS, and healthy controls. A: Degranulation responses by CD107a cell-surface expression ( of positive NK cells) against K562 target cells (natural cytotoxicity) or P815 mouse mastocytoma cells coated with rabbit anti-mouse lymphocyte antibodies (ADCC). B: Intracellular IFN-c expression (percentage of positive NK cells), against K562 target cells or P815 (ADCC). Number of samples from each group: Sepsis group (n = 29), SIRS group (n = 13), and healthy controls (n = 21). A black bar inside the box-and-whiskers plots indicates the median. p(kw): Comparison between healthy, SIRS and Sepsis groups by Kruskal-Wallis test. p: pairwise comparisons between groups (healthy, SIRS, Sepsis) by Kruskal-Wallis post oc methods for multiple comparisons adjusted by step-up Simes method. doi:10.1371/journal.pone.0050446.gDiscussionMortality from severe sepsis and septic shock is still dramatically high, in spite of major advances in critical-care medicine [3]. Massive activation of mononuclear phagocytes by bacterial components and release of proinflammatory cytokines [2] are rapidly compensated for by an anti-inflammatory response, also called immunoparalysis or CARS, which can cause secondary nosocomial infections and death [4,5]. Patients may exhibit both hyper-inflammation and immune paralysis concomitantly, with one being transiently dominant over the other.
